Antibodies targeting ADAM17 reverse neurite outgrowth inhibition by myelin-associated inhibitors is a research paper published in Life Science Alliance (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
New York State Spinal Cord Injury Research Program
Grant: DOH-1 Part 5 IDEA
National Institutes of Health
Grant: R21AG080685
NIH/NCI Cancer Center Support Grant to MSKCC
Grant: P30 CA008748
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 1R21AG080685-01
Targeting the alpha secretase ADAM10 for the treatment of Alzheimer's disease
FWCI
0.48
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals